Moving toward precision and personalized treatment strategies in psychiatry
International Journal of Neuropsychopharmacology · 09.05.2025 · 28 (5)
DOI: 10.1093/ijnp/pyaf025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Neuropsychopharmacology, online erschienen am 21.04.2025. Verfasst von Stefano Comai und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy. Hauptthemen laut MEDLINE: Precision Medicine, Psychiatry, Mental Disorders. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Union's Horizon Europe, European Union’s Horizon Europe.
Abstract (Originalsprache)
Precision psychiatry aims to improve routine clinical practice by integrating biological, clinical, and environmental data. Many studies have been performed in different areas of research on major depressive disorder, bipolar disorder, and schizophrenia. Neuroimaging and electroencephalography findings have identified potential circuit-level abnormalities predictive of treatment response. Protein biomarkers, including IL-2, S100B, and NfL, and the kynurenine pathway illustrate the role of immune and metabolic dysregulation. Circadian rhythm disturbances and the gut microbiome have also emerged as critical transdiagnostic contributors to psychiatric symptomatology and outcomes. Moreover, advances in genomic research and polygenic scores support the perspective of personalized risk stratification and medication selection. While challenges remain, such as data replication issues, prediction model accuracy, and scalability, the progress so far achieved underscores the potential of precision psychiatry in improving diagnostic accuracy and treatment effectiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.
- Department of Biomedical Sciences, University of Padua, Padua, Italy.
- Department of Psychiatry, McGill University, Montreal, QC, Canada.
- IRCSS San Raffaele Scientific Institute, Milan, Italy.
- Unit of Psychiatry, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
- Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada.
ORCID-Profile: Stefano Comai, Raffaele Ferri, Alessandro Serretti
Förderung
- European Union's Horizon Europe
- European Union’s Horizon Europe
Zitieren
APA
Comai, S., Manchia, M., Bosia, M., Miola, A., Poletti, S., Benedetti, F., Nasini, S., Ferri, R., Rujescu, D., Leboyer, M., Licinio, J., Baune, B. T., & Serretti, A. (2025). Moving toward precision and personalized treatment strategies in psychiatry. International Journal of Neuropsychopharmacology, 28(5). https://doi.org/10.1093/ijnp/pyaf025
Vancouver
Comai S, Manchia M, Bosia M, Miola A, Poletti S, Benedetti F, et al. Moving toward precision and personalized treatment strategies in psychiatry. International Journal of Neuropsychopharmacology. 2025;28(5). doi:10.1093/ijnp/pyaf025
BibTeX
@article{Comai2025,
author = {Comai, Stefano and Manchia, Mirko and Bosia, Marta and Miola, Alessandro and Poletti, Sara and Benedetti, Francesco and Nasini, Sofia and Ferri, Raffaele and Rujescu, Dan and Leboyer, Marion and Licinio, Julio and Baune, Bernhard T and Serretti, Alessandro},
title = {Moving toward precision and personalized treatment strategies in psychiatry},
journal = {International Journal of Neuropsychopharmacology},
year = {2025},
volume = {28},
number = {5},
doi = {10.1093/ijnp/pyaf025}
}
EUVIMED